Abstract
The purpose of this study was to examine (1) the association of tumor extract proteins with phospholipid vesicles of varying physiochemical properties, and (2) the adjuvant and carrier properties of liposome-borne tumor antigens in the in vivo induction of an antitumor immune response. Cell surface antigens of the 3-methylcholanthrene-induced fibrosarcoma of C3H/HeJ mice, MCA-F, were extracted using 2.5% 1-butanol. Crude and electrofocused antigen preparations capable of eliciting a protective antitumor immune response were used to prepare liposome vaccines. The incorporation of extract proteins into liposomes formed by butanol dialysis (BVD) was three- to five-fold greater than the encapsulation of protein into the aqueous compartment of multilamellar vesicles (MLV). The electrochemical properties of the BDV had a significant effect on the induction of an antitumor response: Antigens borne on negatively charged, but not uncharged, liposomes were effective in protecting hosts against supralethal tumor challenge, and displayed a specific activity 20- to 50-fold greater than soluble antigen. Antigens carried by MLV were not effective in generating an immunoprotective response. The lipophilic characteristics of butanol-extracted antigens allowed (1) the passive adsorption of immunoprotective tumor antigen onto the surface of preformed vesicles, and (2) adsorption of MCA-F antigen onto the surface of an antigenically distinct tumor MCA-D. In the latter experiment, adsorption of MCA-F-specific antigen onto MCA-D cells resulted in a change in the membrane antigen phenotype as measured by indirect immunofluorescence. Although butanol released a lipophilic moiety from cells which spontaneously reassociated with phospholipid bilayers, no evidence for a lipoidal antigen was obtained when tumor-derived lipids were used as immunogens. This study demonstrates that butanol-extracted tumor antigen is lipophilic without being a lipid, and that negatively charged liposomes can be effective as carriers and adjuvants for tumor antigens in the induction of an antitumor immune response.
Keywords: Tumor Antigen, Phospholipid Bilayer, Antitumor Immune Response, Phospholipid Vesicle, Fluorescence Index
Footnotes
Abbreviations used: BDV, butanol dialysis vesicles; CBE-F, crude butanol extract from the MCA-F tumor; Chol, cholesterol; FI, fluorescense index; PBS, Dulbecco's calcium- and magnesium-free phosphate-buffered saline, pH 7.4; PC, phosphatidylcholine; PG, phosphatidylglycerol; pIEF, preparative isoelectric focusing; MLV, multilamellar vesicles; REV, reverse-evaporation vesicles
References
- 1.Allison AC, Gregoriadis C (1976) Liposomes as immunological adjuvants. Recent Results Cancer Res 58 [DOI] [PubMed]
- 2.Baldwin RW, Baker CR, Embleton MJ, Glaves D, Moore M, Pimm MV. Demonstration of cell surface antigens on chemically induced tumors. Ann NY Acad Sci. 1971;177:268. doi: 10.1111/j.1749-6632.1971.tb35056.x. [DOI] [PubMed] [Google Scholar]
- 3.Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238. doi: 10.1016/S0022-2836(65)80093-6. [DOI] [PubMed] [Google Scholar]
- 4.Burakoff SJ, Englehard VH, Kaufman J, Strominger JL. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens. Nature. 1980;283:495. doi: 10.1038/283495a0. [DOI] [PubMed] [Google Scholar]
- 5.Dancey GF, Yasuda T, Kinsky SC. Effect of liposomal model membrane composition on immunogenicity. J Immunol. 1978;120:1109. [PubMed] [Google Scholar]
- 6.Englehard VH, Guild B, Helenius A, Terhorst C, Strominger J. Reconstitution of purified detergent-soluble HL-A and HL-B antigens into phospholipid vesicles. Proc Natl Acad Sci USA. 1978;75:3230. doi: 10.1073/pnas.75.7.3230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Folch J, Lees M, Sloan-Stanely GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497. [PubMed] [Google Scholar]
- 8.Herrmann SH, Mescher MF. Secondary cytolytic T lymphocyte stimulation by purified H-2Kk in liposomes. Proc Natl Acad Sci USA. 1981;78:2488. doi: 10.1073/pnas.78.4.2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hollander N, Mehdi SQ, Weissman IL, McConnell HM, Kriss JP. Allogeneic cytolysis of reconstituted membrane vesicles. Proc Nalt Acad Sci USA. 1979;76:4042. doi: 10.1073/pnas.76.8.4042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Juliano RL, Stamp D. The effect of particle size and charge on the clearance rates of liposomes and liposome-encapsulated drugs. Biochem Biophys Res Commun. 1975;63:651. doi: 10.1016/S0006-291X(75)80433-5. [DOI] [PubMed] [Google Scholar]
- 11.Kahan BD, Pellis NR, LeGrue SJ, Tanaka T. Immunotherapeutic effects of tumor-specific transplantation antigens released by 1-butanol. Cancer. 1982;49:1168. doi: 10.1002/1097-0142(19820315)49:6<1168::AID-CNCR2820490617>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
- 12.Kinsky SC, Nicolotti RA. Immunological properties of model membranes. Annu Rev Biochem. 1977;46:49. doi: 10.1146/annurev.bi.46.070177.000405. [DOI] [PubMed] [Google Scholar]
- 13.Law LW, Rogers MJ, Appella E. Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: Properties of the solubilized antigens. Adv Cancer Res. 1980;32:201. doi: 10.1016/S0065-230X(08)60362-0. [DOI] [PubMed] [Google Scholar]
- 14.LeGrue SJ. 1-butanol extraction and subsequent reconstitution of membrane components which mediate metastatic phenotype. Cancer Res. 1982;42:2126. [PubMed] [Google Scholar]
- 15.LeGrue SJ, Hearn DR. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials. Cancer Res. 1983;43:5106. [PubMed] [Google Scholar]
- 16.LeGrue SJ, Kahan BD, Pellis NR. Extraction of a murine tumor specific transplantation antigen using 1-butanol. I. Partial purification by isoelectric focusing. JNCI. 1980;65:191. [PubMed] [Google Scholar]
- 17.LeGrue SJ, Allison JP, Macek CM, Pellis NR, Kahan BD. Immunobiological properties of 1-butanol extracted cell surface antigens. Cancer Res. 1981;41:3956. [PubMed] [Google Scholar]
- 18.LeGrue SJ, Macek CM, Kahan BD. Noncytolytic extraction of murine tumor specific transplantation antigens with the nonionic detergent octyl-β-D-glucopyranoside. JNCI. 1982;69:131. [PubMed] [Google Scholar]
- 19.Pellis NR, Kahan BD. Methods to demonstrate the immunogenicity of soluble tumor specific transplantation antigens. I. The immunoprophylaxis assay. Meth Cancer Res. 1976;13:291. [Google Scholar]
- 20.Pellis NR, Yamagishi H, Macek CM, Kahan BD. Specificity and biological activity of extracted murine tumor specific transplantation antigens. Int J Cancer. 1980;26:443. doi: 10.1002/ijc.2910260409. [DOI] [PubMed] [Google Scholar]
- 21.Pellis NR, Yamagishi H, Shulan D, Kahan BD. Use of preparative isoelectric focusing in a Sephadex gel slab to separate immunizing and growth facilitating moieties in crude 3 M KCl extracts of a murine fibrosarcoma. Cancer Immunol Immunother. 1981;11:53. doi: 10.1007/BF00205774. [DOI] [Google Scholar]
- 22.Poste G, Papahadjopolous D. Lipid vesicles as carriers for introducing materials into cultured cells: Influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci USA. 1976;73:1603. doi: 10.1073/pnas.73.5.1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Prehn RT, Main JM. Immunity to methylcholanthrene induced tumors. J Natl Cancer Inst. 1957;18:769. [PubMed] [Google Scholar]
- 24.Raphael L, Tom BH. In vitro induction of primary and secondary xenoimmune responses by liposomes containing human colon tumor cell antigens. Cell Immunol. 1982;71:224. doi: 10.1016/0008-8749(82)90258-1. [DOI] [PubMed] [Google Scholar]
- 25.Raphael L, Tom BH (1984) Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes. Clin Exp Immunol 55 (in press) [PMC free article] [PubMed]
- 26.Raz A, Bucana C, Fogler WE, Poste G, Fidler J. Biochemical, morphological and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 1981;41:487. [PubMed] [Google Scholar]
- 27.Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res. 1982;42:161. [PubMed] [Google Scholar]
- 28.Szoka F, Paphadjopolous D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc Natl Acad Sci USA. 1978;75:4194. doi: 10.1073/pnas.75.9.4194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tanaka T, Yamagishi H, Pellis NR, Kahan BD. Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen. Cancer Immunol Immunother. 1982;13:48. doi: 10.1007/BF00200200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tom BH, Six H. Liposomes and immunobiology. Amsterdam: Elsevier/North Holland; 1980. [Google Scholar]
- 31.Tom BH, Goodwin TJ, Sengupta J, Kahan BD, Rutzky LP. A new approach for the immunogenic presentation of membrane-bound human colon tumor antigens. Immunol Commun. 1982;11:315. doi: 10.3109/08820138209050731. [DOI] [PubMed] [Google Scholar]
- 32.Tyrrell DA, Heath TD, Colley CM, Ryman BE. New aspects of liposomes. Biochim Biophys Acta. 1976;457:259. doi: 10.1016/0304-4157(76)90002-2. [DOI] [PubMed] [Google Scholar]
- 33.Van Rooijen N, Van Nieuwmegan R. Liposomes in immunology: Evidence that their adjuvant effect results from surface exposition of the antigens. Cell Immunol. 1980;49:402. doi: 10.1016/0008-8749(80)90043-X. [DOI] [PubMed] [Google Scholar]